Alimentary Pharmacology & Therapeutics Symposium Series

Cover image for Vol. 1 Issue 1

September 2005

Volume 1, Issue 1

Pages 1–32

  1. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors

    1. Top of page
    2. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors
    3. Session 1: The rheumatologist's view
    4. Session 2: The cardiologist's view
    5. Session 3: The gastroenterologist's view
    6. Session 4: Panel Discussion
    1. Chairmen's introduction (page 1)

      J. M. Scheiman and B. Cryer

      Version of Record online: 26 AUG 2005 | DOI: 10.1111/j.1746-6342.2005.00011.x

  2. Session 1: The rheumatologist's view

    1. Top of page
    2. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors
    3. Session 1: The rheumatologist's view
    4. Session 2: The cardiologist's view
    5. Session 3: The gastroenterologist's view
    6. Session 4: Panel Discussion
  3. Session 2: The cardiologist's view

    1. Top of page
    2. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors
    3. Session 1: The rheumatologist's view
    4. Session 2: The cardiologist's view
    5. Session 3: The gastroenterologist's view
    6. Session 4: Panel Discussion
  4. Session 3: The gastroenterologist's view

    1. Top of page
    2. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors
    3. Session 1: The rheumatologist's view
    4. Session 2: The cardiologist's view
    5. Session 3: The gastroenterologist's view
    6. Session 4: Panel Discussion
  5. Session 4: Panel Discussion

    1. Top of page
    2. Non-steroidal anti-inflammatory drug-induced gastrointestinal damage and the role of proton-pump inhibitors
    3. Session 1: The rheumatologist's view
    4. Session 2: The cardiologist's view
    5. Session 3: The gastroenterologist's view
    6. Session 4: Panel Discussion
    1. Panel discussion: treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations (pages 26–32)

      J. M. SCHEIMAN, B. CRYER, M. ASAKA, F. BERENBAUM, J. BONNET, F. K.-L. CHAN, G. KREJS, A. LANAS, A. WEAVER and F. ZERBIB

      Version of Record online: 26 AUG 2005 | DOI: 10.1111/j.1746-6342.2005.00018.x

SEARCH

SEARCH BY CITATION